Use of Siltuximab for the Treatment of Severe Immune Effector Cell Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell Therapy: Single Center Case Series

Authors :: Marcus J. Geer
David Frame
John Magenau
John Maciejewski
Sarah Anand
Mary Mansour Riwes
Attaphol Pawarode
Pavan Reddy
Gianni B. Scappaticci
Denise Markstrom
Monalisa Ghosh
Source :: Transplantation and Cellular Therapy. 28:S176-S177
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Subjects :: Transplantation
Molecular Medicine
Immunology and Allergy
Cell Biology
Hematology

Tools